Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 30, 2022
Patent Application Number
16885353
Date Filed
May 28, 2020
Patent Citations
Patent Primary Examiner
CPC Code
Therapeutic regimens and uses of mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugates comprising a polyethylene glycol (PEG) moiety attached to a mutant FGF-21 peptide via a glycosyl moiety thereof in the treatment of nonalcoholic steatohepatitis are provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
